N-(2-Methoxy-5-(4-(3-morpholino-3-oxopropyl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)pyridin-3-yl)butane-1-sulfonamide

ID: ALA4240371

PubChem CID: 145983984

Max Phase: Preclinical

Molecular Formula: C25H32N4O7S

Molecular Weight: 532.62

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCS(=O)(=O)Nc1cc(-c2ccc3c(c2)N(CCC(=O)N2CCOCC2)C(=O)CO3)cnc1OC

Standard InChI:  InChI=1S/C25H32N4O7S/c1-3-4-13-37(32,33)27-20-14-19(16-26-25(20)34-2)18-5-6-22-21(15-18)29(24(31)17-36-22)8-7-23(30)28-9-11-35-12-10-28/h5-6,14-16,27H,3-4,7-13,17H2,1-2H3

Standard InChI Key:  RSWYQXNEEKNOBH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
    1.5353  -19.0967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9481  -18.3909    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1305  -18.3864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9522  -20.0294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9522  -20.8466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6575  -21.2511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3627  -20.8466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3627  -20.0294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6575  -19.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0694  -21.2596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0662  -22.0778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7693  -22.4873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7756  -20.8510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4831  -21.2651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4765  -22.0849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1793  -22.4983    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8932  -22.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8998  -21.2766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1926  -20.8586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6112  -20.8744    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6575  -18.7995    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2433  -19.6229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5368  -20.0336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1980  -20.0414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9439  -17.5737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6496  -17.1616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6454  -16.3444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3511  -15.9322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9085  -19.6376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9139  -18.8204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6244  -18.4166    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3314  -18.8352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0397  -18.4348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0494  -17.6173    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3446  -17.2018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6302  -17.6038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2090  -18.4071    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  4 22  1  0
 22 23  1  0
 19 24  1  0
  2 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 24 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 31 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 30 37  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4240371

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 532.62Molecular Weight (Monoisotopic): 532.1992AlogP: 2.27#Rotatable Bonds: 10
Polar Surface Area: 127.37Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.89CX Basic pKa: 0.79CX LogP: 0.47CX LogD: 0.36
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.49Np Likeness Score: -1.74

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source